These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38511407)

  • 1. Targeting Epstein-Barr virus in multiple sclerosis: when and how?
    Giovannoni G
    Curr Opin Neurol; 2024 Jun; 37(3):228-236. PubMed ID: 38511407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
    Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
    Front Immunol; 2021; 12():757302. PubMed ID: 34790199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
    Angelini DF; Serafini B; Piras E; Severa M; Coccia EM; Rosicarelli B; Ruggieri S; Gasperini C; Buttari F; Centonze D; Mechelli R; Salvetti M; Borsellino G; Aloisi F; Battistini L
    PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
    Veroni C; Aloisi F
    Front Immunol; 2021; 12():665718. PubMed ID: 34305896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus and multiple sclerosis.
    Salvetti M; Giovannoni G; Aloisi F
    Curr Opin Neurol; 2009 Jun; 22(3):201-6. PubMed ID: 19359987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus in multiple sclerosis.
    Bagert BA
    Curr Neurol Neurosci Rep; 2009 Sep; 9(5):405-10. PubMed ID: 19664371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies.
    Bar-Or A; Pender MP; Khanna R; Steinman L; Hartung HP; Maniar T; Croze E; Aftab BT; Giovannoni G; Joshi MA
    Trends Mol Med; 2020 Mar; 26(3):296-310. PubMed ID: 31862243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
    Ruprecht K
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
    Pender MP
    Autoimmun Rev; 2009 Jun; 8(7):563-8. PubMed ID: 19254880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.
    Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F
    J Neuroinflammation; 2018 Jan; 15(1):18. PubMed ID: 29338732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and multiple sclerosis.
    Soldan SS; Lieberman PM
    Nat Rev Microbiol; 2023 Jan; 21(1):51-64. PubMed ID: 35931816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
    J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP; Mautner J; Mitterreiter JG; Hintzen RQ; Verjans GM
    Mult Scler; 2016 Mar; 22(3):279-91. PubMed ID: 26041797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
    Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
    Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
    Pender MP; Csurhes PA; Smith C; Beagley L; Hooper KD; Raj M; Coulthard A; Burrows SR; Khanna R
    Mult Scler; 2014 Oct; 20(11):1541-4. PubMed ID: 24493474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.